AI
ITCI
AdvisorShares Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,077
| Closed | -$406K | – | 340 |
|
2025
Q1 | $406K | Sell |
3,077
-186
| -6% | -$24.5K | 0.08% | 174 |
|
2024
Q4 | $273K | Buy |
3,263
+458
| +16% | +$38.3K | 0.05% | 205 |
|
2024
Q3 | $205K | Sell |
2,805
-900
| -24% | -$65.9K | 0.04% | 217 |
|
2024
Q2 | $252K | Sell |
3,705
-870
| -19% | -$59.2K | 0.04% | 214 |
|
2024
Q1 | $317K | Buy |
4,575
+424
| +10% | +$29.3K | 0.05% | 208 |
|
2023
Q4 | $297K | Sell |
4,151
-1,621
| -28% | -$116K | 0.07% | 207 |
|
2023
Q3 | $301K | Buy |
5,772
+1,057
| +22% | +$55.1K | 0.08% | 174 |
|
2023
Q2 | $299K | Sell |
4,715
-115
| -2% | -$7.28K | 0.09% | 179 |
|
2023
Q1 | $262K | Sell |
4,830
-399
| -8% | -$21.6K | 0.08% | 176 |
|
2022
Q4 | $277K | Sell |
5,229
-2,847
| -35% | -$151K | 0.08% | 200 |
|
2022
Q3 | $376K | Buy |
+8,076
| New | +$376K | 0.1% | 193 |
|